Guidelines provide prevention and treatment strategies for non-alcoholic fatty liver disease, indicating significant health implications.
Non-alcoholic fatty liver disease (NAFLD) is an acquired metabolic stress-induced liver disease associated closely with genetic susceptibility and insulin resistance (IR), the spectrum of the disease includes non-alcoholic fatty liver (NAFL), non-alcoholic steatohepatitis (NASH) and related liver cirrhosis, and hepatocellular carcinoma (HCC).1,2 This article is protected by copyright. All rights reserved.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: